World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit 2015

OMICS International is pleased to announce its annual conferences 2015 and 2016. One of the conference is BABE-2015

Important highlights of the BABE-2015 Conference include topics like Emerging Bioavailability and Bioequivalence Studies, Bio-analytical Methodology, Contemporary Challenges of Drug Design, Discovery and Development, Regulatory Policies, Procedures and Prerequisites for Clinical Research, Managing BA/BE Studies, Relevance of Genetics to BA/BE in Drug Development, Bioavailability, Bioequivalence and Drug Product Selection, Advances in Assessment of Bioequivalence, Need for Conducting BA/BE Studies, Metabolic Pathways and Changes in Nutrient Bioavailability, Factors Affecting Bioavailability, Study Designs, Clinical Pharmacology and Therapeutics.

BABE-2015 Conferences attains greater global significance as BABE-2015 play a significance role in the future of pharmaceutical and clinical research. Conference aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. Bioavailability refers to the extent to which a drug is absorbed into the body and is thus available to act upon the drug's intended target, also known as the "site of action. These studies are also important in the post approval period in the presence of certain manufacturing changes. information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners.